• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diabetes Res Clin Pract . Baseline Characteristics and Risk Factors for Short-Term Outcomes in 132 COVID-19 Patients With Diabetes in Wuhan China:

tetano

Editor, Senior Moderator
Diabetes Res Clin Pract


. 2020 Jul 2;108299.
doi: 10.1016/j.diabres.2020.108299. Online ahead of print.
Baseline Characteristics and Risk Factors for Short-Term Outcomes in 132 COVID-19 Patients With Diabetes in Wuhan China: A Retrospective Study


Yumin Li[SUP] 1 [/SUP], Xiaoyu Han[SUP] 2 [/SUP], Osamah Alwalid[SUP] 3 [/SUP], Yue Cui[SUP] 4 [/SUP], Yukun Cao[SUP] 5 [/SUP], Jia Liu[SUP] 6 [/SUP], Jin Gu[SUP] 7 [/SUP], Lixia Wang[SUP] 8 [/SUP], Yanqing Fan[SUP] 9 [/SUP], Heshui Shi[SUP] 10 [/SUP]



Affiliations
Free PMC article

Abstract

Aims: To investigate the clinical characteristics, laboratory findings and high- resolution CT (HRCT) features and to explore the risk factors for in-hospital death and complications of coronavirus disease 2019 (COVID-19) patients with diabetes.
Methods: From Dec 31, 2019, to Apr 5, 2020, a total of 132 laboratory-confirmed COVID-19 patients with diabetes from two hospitals were retrospectively included in our study. Clinical, laboratory and chest CT data were analyzed and compared between the two groups with an admission glucose level of ≤11mmol/L (group 1) and >11mmol/L (group 2). Logistic regression analyses were used to identify the risk factors associated with in-hospital death and complications.
Results: Of 132 patients, 15 died in hospital and 113 were discharged. Patients in group 2 were more likely to require intensive care unit care (21.4% vs. 9.2%), to develop acute respiratory distress syndrome (ARDS) (23.2% vs. 9.25%) and acute cardiac injury (12.5% vs. 1.3%), and had a higher death rate (19.6% vs. 5.3%) than group 1. In the multivariable analysis, patients with admission glucose of >11 mmol/l had an increased risk of death (OR: 7.629, 95%CI: 1.391-37.984) and in-hospital complications (OR: 3.232, 95%CI: 1.393-7.498). Admission d-dimer of ≥1.5 μg/mL (OR: 6.645, 95%CI: 1.212-36.444) and HRCT score of ≥10 (OR: 7.792, 95%CI: 2.195-28.958) were associated with increased odds of in-hospital death and complications, respectively.
Conclusions: In COVID-19 patients with diabetes, poorly-controlled blood glucose (>11mmol/L) may be associated with poor outcomes. Admission hyperglycemia, elevated d-dimer and high HRCT score are potential risk factors for adverse outcomes and death.

Keywords: Coronavirus disease 2019; Diabetes mellitus; High- resolution CT; Risk factors.
 
Back
Top Bottom